Insights

Innovative Drug Delivery Innocore's focus on long-acting and minimally invasive injectable formulations for peptides and biologics positions it as a strategic partner for pharmaceutical companies seeking advanced drug delivery solutions to enhance therapeutic efficacy and patient compliance.

Partnership Opportunities The company's expertise in developing proprietary biodegradable polymer platforms and collaborative licensing presents significant opportunities for pharmaceutical and biotech firms looking to expand their pipeline with innovative injectable and implantable products.

Market Engagement Participation in major industry events like BIO International, NLSDays, and DDF Summit indicates Innocore’s active engagement with the global life sciences community, which can facilitate networking and sales opportunities with potential clients and partners.

Emerging Market Potential With a focus on controlled release and stable formulations, Innocore is well-positioned to address the growing demand for sustained-release biologics and small molecules, providing avenues for sales expansion into specialty therapeutics markets.

Growth and Funding Although current revenue is modest, Innocore’s innovative platform and scheduled events signal potential for scaling with targeted business development efforts aimed at attracting strategic investments and expanding client collaborations in the pharmaceutical manufacturing sector.

Similar companies to Innocore

Innocore Tech Stack

Innocore uses 8 technology products and services including AppNexus, Facebook Pixel, Cookiebot, and more. Explore Innocore's tech stack below.

  • AppNexus
    Advertising
  • Facebook Pixel
    Analytics
  • Cookiebot
    Cookie Compliance
  • LinkedIn
    Online Community Software
  • X-XSS-Protection
    Security
  • Google Tag Manager
    Tag Management
  • Minitab
    Visualisation Software
  • Apache
    Web Servers

Media & News

Innocore's Email Address Formats

Innocore uses at least 1 format(s):
Innocore Email FormatsExamplePercentage
First@innocorepharma.comJohn@innocorepharma.com
93%
First.Last@innocorepharma.comJohn.Doe@innocorepharma.com
7%

Frequently Asked Questions

Where is Innocore's headquarters located?

Minus sign iconPlus sign icon
Innocore's main headquarters is located at 1 L.j Zielstraweg Groningen, Groningen 9713 gx Netherlands. The company has employees across 2 continents, including EuropeNorth America.

What is Innocore's official website and social media links?

Minus sign iconPlus sign icon
Innocore's official website is innocorepharma.com and has social profiles on LinkedIn.

What is Innocore's SIC code NAICS code?

Minus sign iconPlus sign icon
Innocore's SIC code is 8731 - Commercial Physical and Biological Research NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does Innocore have currently?

Minus sign iconPlus sign icon
As of April 2026, Innocore has approximately 50 employees across 2 continents, including EuropeNorth America. Key team members include Ceo: H. D. B.Chief Business Officer: M. B.Chief Operating Officer: B. K.. Explore Innocore's employee directory with LeadIQ.

What industry does Innocore belong to?

Minus sign iconPlus sign icon
Innocore operates in the Pharmaceutical Manufacturing industry.

What technology does Innocore use?

Minus sign iconPlus sign icon
Innocore's tech stack includes AppNexusFacebook PixelCookiebotLinkedInX-XSS-ProtectionGoogle Tag ManagerMinitabApache.

What is Innocore's email format?

Minus sign iconPlus sign icon
Innocore's email format typically follows the pattern of First@innocorepharma.com. Find more Innocore email formats with LeadIQ.

When was Innocore founded?

Minus sign iconPlus sign icon
Innocore was founded in 2003.

Innocore

Pharmaceutical ManufacturingGroningen, Netherlands11-50 Employees

Innocore specializes in the formulation, process development, and manufacturing of long acting and minimally invasive injectable drug delivery products for peptide and biologic therapeutics. 


InnoCore offers a unique and highly tunable polymer platform to control the delivery drug compounds, including small molecules (e.g. peptides and low solubles) and biologics (e.g. proteins and antibodies). 

Our proprietary polymer platform features a variety of benefits to your API's such as:
- solving toxicity challenges
- maintaining/increasing stability and structural integrity of sensitive compounds (e.g. by applying low temperature process conditions during manufacturing)
- sustained release of of drug molecules from days up to at least 6 months
- precise control over particle size (preventing absorption by macrophages and ensuring injectability)
- ensuring smooth bioavailability
- enabling the use of small needle sizes for patient compliance

By merging developmental collaborations and licensing partnerships with our exclusive SynBiosys biodegradable polymer technologies, we generate innovative injectable and implantable drug delivery products. 

We invite you to navigate through our website and discover how we can enhance the performance of your device and/or drug and add value to your product pipeline.

Section iconCompany Overview

Headquarters
1 L.j Zielstraweg Groningen, Groningen 9713 gx Netherlands
SIC Code
8731 - Commercial Physical and Biological Research
NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Founded
2003
Employees
11-50

Section iconFunding & Financials

  • $1M

    Innocore's revenue is estimated to be in the range of $1M

Section iconFunding & Financials

  • $1M

    Innocore's revenue is estimated to be in the range of $1M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.